Skip to main content
Account

Peer review reports

From: Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma

Original Submission
24 Jun 2019 Submitted Original manuscript
12 Jul 2019 Reviewed Reviewer Report - Minoru Kanaya
11 Aug 2019 Reviewed Reviewer Report - Luigi Rigacci
7 Oct 2019 Author responded Author comments - Seok Jin Kim
Resubmission - Version 2
7 Oct 2019 Submitted Manuscript version 2
19 Oct 2019 Reviewed Reviewer Report - Minoru Kanaya
24 Oct 2019 Author responded Author comments - Seok Jin Kim
Resubmission - Version 3
24 Oct 2019 Submitted Manuscript version 3
Publishing
28 Oct 2019 Editorially accepted
10 Nov 2019 Article published 10.1186/s12885-019-6303-z

Learn about peer review

Back to article page

Navigation